Nano-X Imaging (NNOX) Current Assets (2019 - 2026)
Nano-X Imaging (NNOX) posted quarterly Current Assets of $51.3 million for Q1 2026, down 24.48% year-on-year from $68.0 million in Q1 2025, and down 23.15% on a QoQ basis from $66.8 million in Q4 2025.
Nano-X Imaging (NNOX) Current Assets (2019 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Current Assets for 8 consecutive years, with $51.3 million the latest figure, recorded in Q1 2026.
- Quarterly Current Assets fell 24.48% year-over-year to $51.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.3 million (down 24.48% YoY) and the FY2025 annual result came in at $66.8 million, down 15.11% from the prior year.
- Current Assets retreated to $51.3 million in Q1 2026 per NNOX's latest filing, from $66.8 million in the prior quarter.
- Over the last five years, Current Assets for NNOX reached as high as $90.6 billion in Q3 2022 and fell as low as $51.3 million in Q3 2025.
- A 5-year average of $15.3 billion and a median of $78.7 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets surged 81031.42% — and 2023, when it slumped 99.91%.
- Year by year, Current Assets stood at $82.5 million in 2022, then grew by 7.49% to $88.6 million in 2023, then dropped by 11.23% to $78.7 million in 2024, then fell by 15.11% to $66.8 million in 2025, then fell by 23.15% to $51.3 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $51.3 million, $66.8 million, and $51.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 4.33 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.45 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 4.10 Bn |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | 51.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.33 Mn |
| Dec 31, 2025 | 66.79 Mn |
| Sep 30, 2025 | 51.31 Mn |
| Jun 30, 2025 | 57.48 Mn |
| Mar 31, 2025 | 67.97 Mn |
| Dec 31, 2024 | 78.68 Mn |
| Sep 30, 2024 | 60.44 Mn |
| Jun 30, 2024 | 69.63 Mn |
| Mar 31, 2024 | 79.03 Mn |
| Dec 31, 2023 | 88.64 Mn |
| Sep 30, 2023 | 97.62 Mn |
| Jun 30, 2023 | 77.52 Mn |
| Mar 31, 2023 | 81.86 Mn |
| Dec 31, 2022 | 82.46 Mn |
| Sep 30, 2022 | 90.61 Bn |
| Jun 30, 2022 | 89.77 Bn |
| Mar 31, 2022 | 78.12 Bn |
| Dec 31, 2021 | 94.86 Mn |
| Sep 30, 2021 | 111.68 Mn |
| Jun 30, 2021 | 154.86 Mn |